Smallridge, R.C., Wartofsky, L., Chopra, I.J., Marinelli, P.V., Broughton, R.E., Dimond, R.C., et al. (1978) Neonatal Thyrotoxicosis: Alterations in Serum Concentrations of LATS-Protector, T4, T3, Reverse T3, and 3, 3’T2. Journal of Pediatrics, 93, 118-120.
http://dx.doi.org/10.1016/S0022-3476(78)80620-9

has been cited by the following article:

• TITLE: Neonatal Graves’ Disease and Cholestatic Jaundice: Case Series and Review of the Literature

  AUTHORS: Osama Almadhoun, Teresa Rivera-Penera, Lauren Lipeski

  KEYWORDS: Neonate, Graves’ Disease, Thyrotoxicosis, Hyperthyroidism, Cholestasis, Hepatitis, Jaundice, Conjugated Hyperbilirubinemia

  JOURNAL NAME: Open Journal of Pediatrics, Vol.5 No.2, June 29, 2015

  ABSTRACT: Cholestatic jaundice and elevated liver enzymes are uncommon, but recognized, manifestations of neonatal thyrotoxicosis. Current guidelines for evaluation of cholestatic jaundice and reviews in Neonatology literature do not discuss hyperthyroidism in the differential diagnosis of cholestatic jaundice. We report two cases of neonatal thyrotoxicosis secondary to neonatal Graves’ disease that presented with cholestatic jaundice and elevated liver enzymes at birth. Early recognition of thyrotoxicosis as a cause of the hepatic disease in the neonate is crucial to prevent unnecessary diagnostic procedures and to initiate timely treatment.